Home › Endometrial Cancer › Mississippi › Jackson
Endometrial Cancer clinical trials in Jackson, MS
3 studies for Endometrial Cancer are looking for participants at sites in and around Jackson (within about 30 miles). Open a study to see who can join and how to contact the study team.
Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer
RecruitingObservational study
- University of Mississippi Medical Center, Jackson
A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
RecruitingPhase 3
- St. Dominic's Hospital ( Site 5004), Jackson
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
RecruitingPhase 3
- Research Site, Jackson
Endometrial Cancer trials in other cities
- Houston, TX69 studies
- New York City, NY53 studies
- Boston, MA50 studies
- Arlington, VA39 studies
- Nashville, TN37 studies
- Los Angeles, CA35 studies
- St. Louis, MO29 studies
- Philadelphia, PA29 studies
- San Antonio, TX27 studies
- Columbus, OH26 studies
- Chicago, IL26 studies
- Queens, NY26 studies
Other studies in Jackson
- Obesity8 studies
- Overweight6 studies
- Breast Cancer5 studies
- Heart Failure5 studies
- Sickle Cell Disease5 studies
- Non-Small Cell Lung Cancer5 studies
- Lung Cancer5 studies
- Prostate Cancer5 studies
- Steatotic Liver Disease5 studies
- Type 2 Diabetes5 studies
- Attention Deficit Hyperactivity Disorder4 studies
- Burkitt Lymphoma4 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.